J&J to invest €100 million into Limerick manufacturing facilities creating 100 new jobs

pharmafile | May 16, 2019 | News story | Manufacturing and Production Ireland, J&J, JJ, Limerick, medical technology, pharma 

Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care manufacturing facilities in Limerick. The expansion is expected to see the creation of 100 new jobs.

The Minister of State for Trade, Employment and Business, Deputy Pat Breen celebrated the investment in calling it a “huge vote of confidence” in Ireland’s mid-west.

“The expansion, supported by the Government through the IDA, reflects the commitment of the Government and its agencies to pursue balanced and sustainable regional development,” Minister Breen said.

Advertisement

“We believe that the new manufacturing roles being introduced in Limerick in 2019 will be foundational in helping us bring new, innovative contact lens products to our patients and customers around the world at an industry-leading pace,” Vision Care’s plant leader, John Lynch said.

The CEO of IDA Ireland – the agency responsible for attracting and retaining foreign investment – Martin Shanahan commented: “The approximately 100 jobs being added, along with those being created in the construction phase, will greatly benefit the economy of the Mid-West region.

“Having a company of this stature continue to expand its operations enhances Ireland’s global reputation as a Medical Technologies centre of excellence and demonstrates how global companies can successfully operate in regional locations. I wish John and his team continued success.”

Louis Goss

Related Content

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed …

Bend Bioscience adds commercial spray drying facility to Georgia site

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …

The Gateway to Local Adoption Series

Latest content